related documents
- A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (PTS) with metastatic colorectal cancer (MCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH PTS Conferences
- A multicenter phase II study of lapatinib in recurrent or metastatic adenoid cystic (ACC) and non-ACC malignant tumors of the salivary glands (MSGT) Conferences
- A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC) Conferences
- Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck Conferences
- Zoledronic acid may improve survival in lung cancer patients with high baseline bone marker levels Conferences